A clinical case of repeat tissue valve replacement for recurrent mitral valve disease
https://doi.org/10.17802/2306-1278-2018-7-4S-118-122
Abstract
The clinical case reports the experience of successful repeat surgical treatment of a 65-year-old patient with recurrent mitral valve disease. The use of tissue valve prostheses in the treatment of acquired heart disease allowed avoiding anticoagulant therapy in the postoperative period. In addition, the use of new surgical methods of treatment (valve-in-valve technique) contributed to a significant reduction in the risk of surgical complications during the third heart valve replacement. Thus, the use of tissue heart valves, timely diagnosis of valve dysfunction, as well as the use of novel technologies which allows reducing the risk ensure achieving optimal outcome, extending and improving the quality of life of the patient.
About the Authors
A. N. Stasev
Federal State Budgetary Institution Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Competing Interests: Нет конфликта интересов
Russian Federation
Stasev Alexander N. - PhD, researcher at the Laboratory of Bioprosthetic Replacement.
6, Sosnoviy Blvd., Kemerovo, 650002
Competing Interests: Нет конфликта интересов
Yu. N. Odarenko
Federal State Budgetary Institution Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Competing Interests: Нет конфликта интересов
Russian Federation
Odarenko Yuri N. - MD, PhD, the Head of the Laboratory of Bioprosthetic Replacement.
6, Sosnoviy Blvd., Kemerovo, 650002
Competing Interests: Нет конфликта интересов
S. G. Kokorin
Federal State Budgetary Institution Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Competing Interests: Нет конфликта интересов
Russian Federation
Kokorin Stanislav G. - PhD, Leading Researcher the Laboratory of Bioprosthetic Replacement.
6, Sosnoviy Blvd., Kemerovo, 650002
Competing Interests: Нет конфликта интересов
N. V. Rutkovskaya
Federal State Budgetary Institution Research Institute for Complex Issues of Cardiovascular Diseases; State Budgetary Healthcare Institution of the Kemerovo Region Kemerovo Regional Clinical Cardiology Dispensary n.a. Academician L.S. Barbarash
Russian Federation
Competing Interests: Нет конфликта интересов
Russian Federation
Rutkovskaya Natalia V. - PhD, senior researcher at the Laboratory of Bioprosthetic Replacement.
6, Sosnoviy Blvd., Kemerovo, 650002
Competing Interests: Нет конфликта интересов
Yu. V. Levadin
Federal State Budgetary Institution Research Institute for Complex Issues of Cardiovascular Diseases
Russian Federation
Competing Interests: Нет конфликта интересов
Russian Federation
Levadin Yurij V. - cardiovascular surgeon at the Cardiac Surgery Department.
6, Sosnoviy Blvd., Kemerovo, 650002
Competing Interests: Нет конфликта интересов
L. S. Barbarash
Federal State Budgetary Institution Research Institute for Complex Issues of Cardiovascular Diseases; State Budgetary Healthcare Institution of the Kemerovo Region Kemerovo Regional Clinical Cardiology Dispensary n.a. Academician L.S. Barbarash
Russian Federation
Competing Interests: Нет конфликта интересов
Russian Federation
Barbarash Leonid S. - PhD, Professor, Academician of the Russian Academy of Sciences, Chief Researcher.
6, Sosnoviy Blvd., Kemerovo, 650002
Competing Interests: Нет конфликта интересов
References
1. Vohra H.A., Whistance R.N., Roubelakis A., Burton A., Barlow C.W., Tsang G.M., Livesey S.A., Ohri S.K. Outcome after redo-mitral valve replacement in adult patients: a 10-year single-centre experience. Interact Cardiovasc Thorac Surg. 2012 May 1;14(5):575-9. doi:10.1093/icvts/ivs005
2. de Almeida Brandao C.M., Pomerantzeff PM., Souza L.R., Tarasoutchi F., Grimberg M., Ramires J.A., Almeida de Oliveira S. Multivariate analysis of risk factors for hospital mortality in valvular reoperations for prosthetic valve dysfunction. Eur J Cardiothorac Surg. 2002 Dec;22(6):922-6.
3. Onorati F., Perrotti A., Reichart D., Mariscalco G., Della Ratta E., Santarpino G. et al. Surgical factors and complications affecting hospital outcome in redo mitral surgery: insights from a multicentre experience.Eur J Cardiothorac Surg. 2016 May;49(5):e127-33. doi: 10.1093/ejcts/ezw048.
4. Onorati F., Biancari F., De Feo M., Mariscalco G., Messina A., Santarpino G. et al. Mid-term results of aortic valve surgery in redo scenarios in the current practice: results from the multicentre European RECORD (REdo Cardiac Operation Research Database) initiative. Eur J Cardiothorac Surg. 2015 Feb;47(2):269-80. doi: 10.1093/ejcts/ezu116.
5. Jamieson W.R., Burr L.H., Miyagishima R.T., Janusz M.T., Fradet G.J., Lichtenstein S.V, Ling H. Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment. Circulation. 2003 Sep 9;108(90101):98II--102. 10.1161/01.cir.0000089184.46999.f4
6. Akins C., Miller D., Turina M., Kouchoukos N., Blackstone E., Grunkemeier G. et al. Guidelines for Reporting Mortality and Morbidity After Cardiac Valve Interventions. Ann Thorac Surg. 2008 Apr;85(4):1490-5. Doi: 10.1016/j.athoracsur.2007.12.082
7. Jones J.M., O’Kane H., Gladstone D.J., Sarsam M.A., Campalani G., MacGowan S.W., Cleland J., Cran G.W. Repeat heart valve surgery: Risk factors for operative mortality. J Thorac Cardiovasc Surg. 2001 Nov;122(5):913-8. Doi: 10.1067/mtc.2001.116470
8. Maciejewski M., Piestrzeniewicz K., Bielecka-Dabrowa A., Walczak A. Biological artificial valve dysfunction - singlecentre, observational echocardiographic study in patients operated on before age 65 years. Arch Med Sci. 2011;6:993-9. Doi: 10.5114/aoms.2011.26611
Review
For citations:
Stasev A.N., Odarenko Yu.N., Kokorin S.G., Rutkovskaya N.V., Levadin Yu.V., Barbarash L.S. A clinical case of repeat tissue valve replacement for recurrent mitral valve disease. Complex Issues of Cardiovascular Diseases. 2018;7(4S):118-122. (In Russ.) https://doi.org/10.17802/2306-1278-2018-7-4S-118-122
Views:
598
